IJ
Innovative Health Initiative Joint Undertaking (IHI JU)

Establishing Ortho and Cardiology Ambulatory Surgical Centres in Europe

Funds one project to build the infrastructure, training and digital tools needed to run same-day orthopaedic and cardiology surgical centres in Europe.

IHI runs on a public-private funding model, and this topic carries IHI's own additional eligibility rule requiring roughly 45% industry contribution to the project, delivered through in-kind contributions (tracked under IHI-specific budget categories such as IKOP and IKAA) alongside the cash EU grant paid to non-industry beneficiaries. Legal entities established in the UK or Canada are specificall…

This topic wants a practical framework for setting up ambulatory surgical centres in orthopaedics and cardiology — covering infrastructure, medical technology, training and enhanced-recovery protocols — plus a clinical database and economic evidence base to support their wider adoption. It also wants an interoperable IT solution linking pre-procedure, in-procedure and post-discharge home-monitoring data.

CycleiHow often this grant runs - e.g. annually, on a rolling basis, or a one-off call.No fixed schedule
Next deadlineiThe next date applications are due. Rolling means you can apply any time.-
Decision timeiTypical time from the deadline to the funder's decision.-
Project durationiHow long the funded work is expected to run.-
Award typeiThe form of funding - grant, equity, loan, tax credit, etc.Grant
Match fundingiThe share of project costs you must cover yourself. 0% = fully funded.-
Funding pooliThe total budget available across all awards in this round.€37.2M

Sign up free to see the funding breakdown

Sign up free to see the industries in scope

Sign up free to see the full eligibility

Sign up free to see how to apply

Sign up free to see what you submit

Sign up free to see the timeline

Sign up free to see where teams trip up

Guides for this application

All guides →
IJ
Open

An AI Foundation Toxicology Model and Framework to Support Waiving a Second Species in Drug Safety Studies

🇨🇦IHI JU · European Union

Funds development of an AI toxicology model that lets drug developers waive costly second-species animal safety testing.

MedtechAI
€9MOct'26
IJ
Open

Decode the Immunoscience of age-related diseases

🇪🇺IHI JU · European Union

Funds a research consortium that studies why immune-mediated diseases behave differently when they first strike older adults and hunts for biomarkers to predict them.

BiotechMedtech
€9.2MOct'26
IJ
Open

IHI European HealthCare Incubator Network

🇨🇦IHI JU · European Union

Funds a pan-European industry-and-academia incubator network that re-grants up to EUR 2,000,000 each to early-stage healthcare startups.

MedtechBiotech
€35MOct'26
IJ
Closed

AI-Powered Signal Detection in Pharmacovigilance

🇪🇺IHI JU · European Union

Funds one project to build AI algorithms, data-source guidance and practical tools for faster, more accurate detection of drug safety signals.

MedtechAI
€8.9M
IJ
Closed

Boosting innovation for a better understanding of the determinants of health

🇪🇺IHI JU · European Union

Funds public-private research on the determinants of health, from prevention and early diagnosis to new vaccine strategies and disease-outbreak preparedness.

Medtech
€8M – €30M
IJ
Closed

Boosting innovation for better assessment of the added value of innovative integrated healthcare solutions

🇪🇺IHI JU · European Union

Funds public-private research on new health technology assessment methods that value combined, integrated healthcare innovations fairly.

Medtech
€5M – €9.8M
Ministero delle Imprese e del Made in Italy logo
Open

STEP / Critical and Emerging Technologies — 14 (Tecnologie Critiche ed Emergenti)

🇮🇹MIMIT · Italy

Funds Italian companies in southern regions to develop critical innovation in climate, health, and materials.

AIClimate Tech+6
€1M – €20M
European Commission logo
Scheduled

Clinical trials for advancing innovative interventions for neurodegenerative diseases

🇪🇺European Commission · European Union

Funds early clinical trials of safer, more effective interventions for non-rare neurodegenerative diseases.

MedtechBiotech
€10MApr'27
European Commission logo
Scheduled

Mission Soil and Cancer: Living Labs for Carcinogenic Contamination

🇪🇺European Commission · European Union

Funds two €12M projects using living labs to remediate carcinogenic soils and trace cancer risks through people, food, water and air.

Climate TechMedtech+2
€12MSep'27
European Commission logo
Scheduled

European Partnership for Pandemic Preparedness (Phase 2)

🇪🇺European Commission · European Union

Funds the next phase of Europe’s pandemic-preparedness partnership, clinical networks and One Health research ecosystem.

BiotechMedtech
€63MApr'27
Department for Science, Innovation and Technology logo
Open

Life Sciences Transformational R&D Investment Fund (TRIF) Pilot

🇬🇧DSIT · United Kingdom

Capital grants for large-scale UK life sciences R&D investments.

BiotechMedtech+1
£5M – £25MApr'28
European Commission logo
Scheduled

Innovative Antimicrobials Against Resistant Pathogens

🇪🇺European Commission · European Union

Funds antibacterial and antifungal therapies that expand treatment options against antimicrobial-resistant infections.

BiotechMedtech
€8M – €10MApr'27